Daniel Schneiderman - CHIEF FINANCIAL OFFICER at Entero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
ENTO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Daniel Schneiderman since 12/23/2023

Holdings reported by Daniel Schneiderman for Entero Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock option (right to buy) 10K Jan 3, 2022 Direct Common stock, par value $0.0001 per share

Transactions reported by Daniel Schneiderman for Entero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.